Assessing Reasons for Treatment and Treatment Type in Females with Bleeding Disorders
Click here to read Presented at ASH in San Diego 2023. Dr. Danielle Nance of FTFW was an author. It argues for prophylaxis for women with ABRs of 2 or...
Click here to read Presented at ASH in San Diego 2023. Dr. Danielle Nance of FTFW was an author. It argues for prophylaxis for women with ABRs of 2 or...
Click here to view our 2023 Advancement to Serve Female Bleeders Report
Read More Here This is the National Bleeding Disorder Foundation’s website dedicated to educating women on bleeding disorders. There are a variety of videos, documents, and other information on how...
Read More Here From abstract: In 2004, 766 questionnaires were sent, and 546 women responded (80%). Of these, 274 were carriers of hemophilia A or B. The median clotting factor...
Read More Here The findings of the B-HERO-S study reveal potential unmet needs of some patients with mild-moderate hemophilia B, and the results may be leveraged to inform patient outreach...